Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,25 CAD | +2,46% | -13,79% | -46,35% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Simon Beaudoin
FOU | Founder | 40 | 18-07-17 |
Founder | 51 | 18-07-17 | |
P. Meagher
DFI | Director of Finance/CFO | 39 | 18-09-20 |
Moutih Rafei
CTO | Chief Tech/Sci/R&D Officer | 42 | 09-10-20 |
Carrie Cesarone
SEC | Corporate Secretary | 58 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 51 | 18-07-17 | |
P. Meagher
DFI | Director of Finance/CFO | 39 | 18-09-20 |
Raimar Löbenberg
CHM | Chairman | 58 | 05-01-21 |
Moutih Rafei
CTO | Chief Tech/Sci/R&D Officer | 42 | 09-10-20 |
Director/Board Member | 62 | 05-01-21 | |
Riam Shammaa
BRD | Director/Board Member | - | 09-11-21 |
Kwin Grauer
BRD | Director/Board Member | - | 09-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 536 673 | 43 386 673 ( 95,28 %) | 0 | 95,28 % |
Bedrijfsgegevens
Defence Therapeutics Inc
200 Burrard Street Suite 1680
V6C 3L6, Vancouver
+
http://www.defencetherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,35% | 41,49 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |